aberrations and suit sufficient to tolerate FCR therapy, may still be excellent candidates for that latter, with the benefit currently being that this cure is usually done in six months when ibrutinib have to be taken indefinitely. System ini menonjol dalam industri yang telah berubah ini, sebaga